Tag: FDA approval

4 predictions tagged with "FDA approval".

Synchron Files The First Premarket Approval (PMA) Application With The FDA For A Permanently Implanted BCI, The Stentrode, By The End Of 2027.
The First In Vivo CRISPR-Cas9 Gene Editing Therapy, Lonvoguran Ziclumeran (Lonvo-z), Is Expected To Receive US FDA Approval In 2027 For Hereditary Angioedema.
Gene Therapies Are Expected To Gain Widespread Approval For Rare Diseases And Enter Clinical Use.
Deep Brain Stimulation (DBS) Is Expected To Gain Approval For Treatment-resistant Depression.